๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-05-14

Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements (NCT07599696)

Speech Amplification Devices for Parkinson and Related Diseases: Talker- and Technology-Driven Enhancements

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿง  Behavioral & Psychological Program Sponsor: Michigan State University

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The proposed research aims to investigate the use of speech amplification devices as a potential treatment option for people with Parkinson's disease and related disorders who exhibit hypophonia, a voice disorder that affects over half of those with Parkinson's disease. By characterizing the acoustic and perceptual effects of speech amplification and identifying ways to optimize outcomes through talker- and device-specific enhancements, this project seeks to develop personalized, evidence-based treatment options for hypophonia. The current proposal will move this effort forward by systematically eliciting and modifying speech amplification device output that leverage both behavioral and technological approaches.

Who can join: Review the eligibility criteria below.

Location: Michigan State University โ€” East Lansing, Michigan

Age range: 50 Years

๐Ÿงช Interventions in This Study

  • Behavioral speech strategies + speech amplification (BEHAVIORAL)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Michigan State University โ€” East Lansing, Michigan

๐Ÿ“ž Contact the Study Coordinator

Phone: (517) 353-6401

Email: thea@msu.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—